- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x ERG: ERGOSTEROL(Non-covalent)
- 16 x CPL: 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
CPL.3: 8 residues within 4Å:- Chain A: F.343, C.346, L.373, Y.377, L.386, E.389, M.440, R.443
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.343, A:L.373, A:Y.377, A:Y.377, A:L.386, A:E.389, A:M.440, A:R.443
CPL.4: 14 residues within 4Å:- Chain A: R.326, C.330, A.333, S.334, I.337, V.465, M.466, A.469, F.472, L.475
- Chain D: L.496, V.499
- Ligands: CPL.5, CPL.8
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: D:L.496, D:V.499, A:A.333, A:F.472, A:L.475
CPL.5: 6 residues within 4Å:- Chain A: F.472, Q.473, M.474, L.475
- Chain D: W.495
- Ligands: CPL.4
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:W.495, A:Q.473, A:L.475
CPL.6: 14 residues within 4Å:- Chain A: L.496, V.499
- Chain B: R.326, C.330, A.333, S.334, I.337, V.465, M.466, A.469, F.472, L.475
- Ligands: CPL.7, CPL.9
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:L.496, A:V.499, B:A.333, B:F.472, B:L.475
CPL.7: 6 residues within 4Å:- Chain A: W.495
- Chain B: F.472, Q.473, M.474, L.475
- Ligands: CPL.6
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.472, B:F.472, B:Q.473, B:L.475, A:W.495, A:W.495
CPL.8: 16 residues within 4Å:- Chain A: I.337, I.341, T.344, T.345, I.348, Y.349, V.465
- Chain D: W.495, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Ligands: CPL.4
12 PLIP interactions:5 interactions with chain A, 7 interactions with chain D- Hydrophobic interactions: A:I.337, A:I.337, A:I.341, A:T.344, A:V.465, D:W.495, D:V.499, D:L.502, D:Y.526, D:P.527, D:L.530
- Hydrogen bonds: D:Y.526
CPL.9: 16 residues within 4Å:- Chain A: W.495, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Chain B: I.337, I.341, T.344, T.345, I.348, Y.349, V.465
- Ligands: CPL.6
12 PLIP interactions:7 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:W.495, A:V.499, A:L.502, A:Y.526, A:P.527, A:L.530, B:I.337, B:I.337, B:I.341, B:T.344, B:V.465
- Hydrogen bonds: A:Y.526
CPL.12: 8 residues within 4Å:- Chain B: F.343, C.346, L.373, Y.377, L.386, E.389, M.440, R.443
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:F.343, B:L.373, B:Y.377, B:Y.377, B:L.386, B:E.389, B:M.440, B:R.443
CPL.13: 14 residues within 4Å:- Chain B: L.496, V.499
- Chain C: R.326, C.330, A.333, S.334, I.337, V.465, M.466, A.469, F.472, L.475
- Ligands: CPL.14, CPL.18
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:L.496, B:V.499, C:A.333, C:F.472, C:L.475
CPL.14: 16 residues within 4Å:- Chain B: W.495, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Chain C: I.337, I.341, T.344, T.345, I.348, Y.349, V.465
- Ligands: CPL.13
12 PLIP interactions:7 interactions with chain B, 5 interactions with chain C- Hydrophobic interactions: B:W.495, B:V.499, B:L.502, B:Y.526, B:P.527, B:L.530, C:I.337, C:I.337, C:I.341, C:T.344, C:V.465
- Hydrogen bonds: B:Y.526
CPL.17: 8 residues within 4Å:- Chain C: F.343, C.346, L.373, Y.377, L.386, E.389, M.440, R.443
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.343, C:L.373, C:Y.377, C:Y.377, C:L.386, C:E.389, C:M.440, C:R.443
CPL.18: 6 residues within 4Å:- Chain B: W.495
- Chain C: F.472, Q.473, M.474, L.475
- Ligands: CPL.13
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:W.495, B:W.495, C:F.472, C:F.472, C:Q.473, C:L.475
CPL.19: 14 residues within 4Å:- Chain C: L.496, V.499
- Chain D: R.326, C.330, A.333, S.334, I.337, V.465, M.466, A.469, F.472, L.475
- Ligands: CPL.20, CPL.21
5 PLIP interactions:2 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:L.496, C:V.499, D:A.333, D:F.472, D:L.475
CPL.20: 6 residues within 4Å:- Chain C: W.495
- Chain D: F.472, Q.473, M.474, L.475
- Ligands: CPL.19
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:F.472, D:F.472, D:Q.473, D:L.475, C:W.495, C:W.495
CPL.21: 16 residues within 4Å:- Chain C: W.495, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Chain D: I.337, I.341, T.344, T.345, I.348, Y.349, V.465
- Ligands: CPL.19
12 PLIP interactions:7 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:W.495, C:V.499, C:L.502, C:Y.526, C:P.527, C:L.530, D:I.337, D:I.337, D:I.341, D:T.344, D:V.465
- Hydrogen bonds: C:Y.526
CPL.24: 8 residues within 4Å:- Chain D: F.343, C.346, L.373, Y.377, L.386, E.389, M.440, R.443
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:F.343, D:L.373, D:Y.377, D:Y.377, D:L.386, D:E.389, D:M.440, D:R.443
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Jesus-Perez, J.J. et al., Structural mechanism of TRPV5 inhibition by econazole. Structure (2024)
- Release Date
- 2024-01-10
- Peptides
- Transient receptor potential cation channel subfamily V member 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x ERG: ERGOSTEROL(Non-covalent)
- 16 x CPL: 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Jesus-Perez, J.J. et al., Structural mechanism of TRPV5 inhibition by econazole. Structure (2024)
- Release Date
- 2024-01-10
- Peptides
- Transient receptor potential cation channel subfamily V member 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.